SUNSHINE PHARMA (06887) purchased approximately 4.76 million shares for around HKD 21.06 million on December 31st.
Dongyang Guangyao (06887) announced that it will spend approximately HKD 21.06 million to repurchase 476,000 shares by December 31, 2025.
SUNSHINE PHARMA (06887) announced the repurchase of approximately 476,000 shares at a cost of approximately HK$21.06 million on December 31, 2025.
Related Articles
TIAN TU CAPITAL (01973): Di Zhe was appointed as the Secretary of the Board of Directors.
SMOORE INTL(06969): Granted a total of 915,000 share options.
SMOORE INTL (06969) issues 545,000 shares of reward shares.
TIAN TU CAPITAL (01973): Di Zhe was appointed as the Secretary of the Board of Directors.
SMOORE INTL(06969): Granted a total of 915,000 share options.
SMOORE INTL (06969) issues 545,000 shares of reward shares.
